Drug Profile
CGP 28237
Alternative Names: ZK 34228Latest Information Update: 15 Aug 1994
Price :
$50
*
At a glance
- Originator Bayer Schering Pharma; Novartis
- Class Anti-inflammatories; Antirheumatics
- Mechanism of Action Prostaglandin synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders